Drug-resistant recurrent symptomatic persistent atrial fibrillation
Conditions
Interventions
None listed
Sponsors
Yamane Teiichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients over the age of 18 2. Patients scheduled for ablation with SATAKE-HotBalloon catheter for persistent atrial fibrillation
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with a life expectancy of less than 1 year due to some disease 2. Patients who requested refusal regarding the use of information in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 12 months postoperative success rate (Including touch-up cases) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Acute phase success rate (including touch-up cases) Percentage of study subjects with isolated pulmonary veins (RSPV, RIPV, LSPV, LIPV) Isolated lungs for ablated pulmonary veins (RSPV, RIPV, LSPV, LIPV) Percentage of veins Success or failure of isolation: Successful if the potential is 0.1 mV or less or if the pulmonary vein potential and the left atrial potential are not synchronized. 2. 12 months postoperative safety Occurrence of all adverse events related to catheter ablation during the observation period | — |
Contacts
Public ContactFumiyuki Iida
EPS Corporation
Outcome results
None listed